Company News

SkinMedica To License NYU Technology

Agreement is expected to lead to a new skin lightening range.

Author Image

By: TOM BRANNA

Editor

SkinMedica, Inc. and New York University have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented atNew York University. “Our scientific discovery involves natural products that act by an entirely novel mechanism to modulate skin pigmentation,” said Seth J. Orlow, M.D., Ph.D., chair of the Ronald O. Perelman Department of Dermatology at NYU, and Director of the Program in Cutaneous Biology and NYU Langone Medical Cen...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters